Seattle Genetics, Inc.

Website Links

Description

We use the information you provide to us for our legitimate business purposes, including to respond to your requests and to provide you with information you might have requested. We will also use information to improve our products and services, or to customize your interaction with us, including the type of content of ours that you see online or receive from us. We use information to analyze customer interests as well, including analyzing website trends, and to better understand your needs and how we can improve our websites and products.

Seattle Genetics is a biotechnology company focused on the development and commercialization of innovative antibody-based therapies for the treatment of cancer. Seattle Genetics is leading the field in developing antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of antibodies to deliver cell-killing agents directly to cancer cells.

Seattle Genetics is a biotechnology company focused on developing and commercializing innovative, empowered antibody-based therapies for the treatment of cancer. We are the industry leader in antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells.

Some of our websites or interactive features may contain links to third party websites or services that are not under our control. Such links do not constitute an endorsement of those third parties or the content displayed therein. You acknowledge that we provide these links to you only as a convenience, and you understand that your information will be used as described by the third parties in their privacy policies.

With over 16 years of experience and knowledge in ADC innovation, Seattle Genetics is the leader in developing ADCs, a technology designed to harness the targeting ability of antibodies to deliver cell-killing agents directly to cancer cells. Of the more than 30 ADC candidates in clinical development, greater than 20 utilize Seattle Genetics’ proprietary ADC technology.

Fact sheet

Companies nearby